Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurexan fMRI Study in Stressed Healthy Males
NCT02602275Phase 2Completed
- Sponsor
- Heel
- Start
- Aug 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Neurexan in acute stress reaction (ASR) (2 arms), sponsored by Heel. Primary endpoints: BOLD Activation Changes Within Amygdala During Negative Faces in the Hariri Face Matching Task, Change in Global Functional Connectivity Density of the Amygdala at Rest and 3 more. Started Aug 2015; status: completed.
02
Drugs
Neurexan
03
Conditions
acute stress reaction (ASR)
Beyond the preview
Go deeper on NCT02602275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602275.